Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis

Thorax

Volumn 69, Issue 3, 2014, Pages 247-253

  Flight, William G ^a,b   Bright Thomas, Rowland J ^a,b   Tilston, Peter ^a   Mutton, Kenneth J ^a,b   Guiver, Malcolm ^a   Morris, Julie ^a   Webb, A Kevin ^a,b   Jones, Andrew M ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADENOVIRUS; ADULT; ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG TARGETING; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RHINOVIRUS; INCIDENCE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 3; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY VIRUS; RISK ASSESSMENT; SCORING SYSTEM; SPIROMETRY; SPUTUM CYTODIAGNOSIS; SYMPTOM; THROAT CULTURE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION;

CYSTIC FIBROSIS; VIRAL INFECTION;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 84893959487     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204000     Document Type: Article

References (31)

1. Monto A, Ullman B. Acute respiratory illness in an American community. The Tecumseh study. JAMA 1974; 227:164-9.
2. Fox J, Hall C, Cooney M., et al The Seattle virus watch. II. Objectives, study population and its observation, data processing and summary of illnesses. Am J Epidemiol 1972; 96:270-85.
3. Johnston SL, Pattemore PK, Sanderson G, et al Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
4. Freymuth F, Vabret A, Brouard J., et al Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999; 13:131-9. (Pubitemid 29349101)
5. Rakes GP, Arruda E, Ingram J.M., et al Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159:785-90. (Pubitemid 29137774)
6. Corne JM, Marshall C, Smith S., et al Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359:831-4. (Pubitemid 34233753)
7. Seemungal T, Harper-Owen R, Bhowmik A., et al Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1618-23. (Pubitemid 33124148)
8. Rohde G, Wiethege A, Borg I., et al Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003; 58:37-42. (Pubitemid 36135356)
9. van Ewijk B., van der Zalm M, Wolfs T, et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics 2008; 122:1171-6.
10. Wat D, Gelder C, Hibbitts S., et al The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008; 7:320-8.
11. de Almeida M.B., Zerbinati RM, Tateno A.F., et al Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010; 16:996-9.
12. Collinson J, Nicholson K, Cancio E., et al Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996; 51:1115-22. (Pubitemid 26402824)
13. Smyth A, Smyth R, Tong C., et al Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73:117-20.
14. Conway SP, Simmonds EJ, Littlewood JM Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 1992; 47:112-4.
15. Jones AM, Flight W, Isalska B., et al Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples. Eur Respir J 2011; 38:1486-7.
16. Whitaker P, Etherington C, Denton M., et al A/H1N1 flu pandemic. A/H1N1 and other viruses affecting cystic fibrosis. BMJ 2009; 339.
17. Wark PA, Tooze M, Cheese L., et al Viral infections trigger exacerbations of cystic fibrosis in adults and children. Eur Respir J 2012; 40:510-2.
18. Chattoraj SS, Ganesan S, Jones A.M., et al Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax 2011; 66:333-9.
19. Van Ewijk B., Wolfs T, Aerts P., et al RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 2007; 61: 398-403. (Pubitemid 46569290)
20. Flight WG, Mutton K, Webb A.K., et al The incidence of respiratory virus infection in adults with cystic fibrosis. Pediatr Pulmonol 2012; 47(S35):315.
21. Lee WM, Kiesner C, Pappas T., et al A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS ONE 2007; 2:e966.
22. Fuchs H, Borowitz D, Christiansen D., et al Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994; 331:637-42. (Pubitemid 24276863)
23. Miller MR, Hankinson J, Brusasco V., et al Standardisation of spirometry. Eur Respir J 2005; 26:319-38. (Pubitemid 41079078)
24. Olesen H, Nielsen L, Schiotz P. Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic. Pediatr Pulmono. 2006; 41:1197-204. (Pubitemid 44893874)
25. Andrewes C. Rhinoviruses and common colds. Annu Rev Med 1966; 17:361-70.
26. Wang E, Prober C, Manson B., et al Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984; 311:1653-8. (Pubitemid 15183995)
27. Surveillance of influenza and other respiratory viruses in the UK: 2011-2012 report. Health Protection Agency, 2012. http://www.hpa.org.uk/ Publications/InfectiousDiseases/Influenza/1206influannualreport/
28. Burns JL, Emerson J, Kuypers J., et al Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respi Viruses 2012; 6:218-23.
29. Britto M, Kotagal U, Hornung R., et al Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002; 121:64-72. (Pubitemid 34114229)
30. Sanders DB, Bittner RC, Rosenfeld M, et al Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Resp Crit Care Med 2010; 182:627-32.
31. de Boer K., Vandemheen KL, Tullis E, et al Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax 2011; 66:680-5.